Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
39.71
+0.85 (2.19%)
At close: Dec 15, 2025, 4:00 PM EST
40.50
+0.79 (1.99%)
After-hours: Dec 15, 2025, 7:22 PM EST
Maze Therapeutics Revenue
In the year 2024, Maze Therapeutics had annual revenue of $167.50M.
Revenue (ttm)
$167.50M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
125
Market Cap
1.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 167.50M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMAZE News
- 20 days ago - Maze Therapeutics, Inc. (MAZE) Presents at Jefferies London Healthcare Conference 2025 Prepared Remarks Transcript - Seeking Alpha
- 5 weeks ago - Maze Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights - GlobeNewsWire
- 5 weeks ago - Maze Therapeutics to Present Additional Data Highlighting the Advancement of MZE829 and MZE782 Programs at ASN Kidney Week - GlobeNewsWire
- 5 weeks ago - Maze Therapeutics to Participate in Four Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - San Francisco is making a comeback. So are these stocks from the City by the Bay - CNBC
- 2 months ago - Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors - GlobeNewsWire
- 3 months ago - Maze Therapeutics, Inc. (MAZE) Discuses On MZE782 Phase 1 Healthy Volunteer Trial Results Call (Transcript) - Seeking Alpha
- 3 months ago - Maze Shares Jump As Investors Bet Big On Experimental Treatment's Potential - Benzinga